A panel of cancer experts is recommending against testing for prostate-specific antigen (PSA), the most commonly used prostate cancer screen, in healthy men.
cancer screening
Study: Men May Benefit from Earlier Colonoscopy, But Women Can Wait
Colonoscopies aren’t the most pleasant medical procedures around, but regular colon-cancer screening can potentially save your life. That’s why doctors and most professional medical organizations recommend that all men and women …
Study: Doctors May Be Confused About Cervical Cancer Screening
The U.S. has arguably the world’s best medical tools available — especially when it comes to cancer screening, which has significantly reduced the mortality rates of serious killers such as breast and colorectal cancer in the …
Life Expectancy Lags in the U.S., But It May Be on the Upswing
On average Americans don’t live as long as people in many other wealthy nations, and they’re less healthy overall — this, despite the fact that the U.S. spends more on health care than any other nation in the world. A new …
Regular prostate cancer screening still not advised
The American Cancer Society released updated prostate cancer screening recommendations yesterday that largely reiterate existing guidance—advising men to discuss the issue with their physicians and make a decision about the potential benefits of screening based on their individual medical histories and age. The new recommendations
…
Can mammograms increase cancer risk for some women?
As women are still struggling to make sense of the new mammogram recommendations released in November by the U.S. Preventive Services Task Force, research presented today at a meeting of the Radiological Society of North America suggests that, for women at high risk of developing breast cancer, who are often urged to undergo annual
…
Rethinking the benefits of breast and prostate cancer screening
For two decades, the public-health message has been that cancer screening saves lives. In some cases, especially with cancers of the cervix and colon, screening does, in fact, work as it should: sniffing out disease at its earliest and most curable stages. But for breast and prostate cancers—two of the most widespread in the U.S.—the …